In this study, researchers developed and evaluated a blood-based cell-free and exosomal miRNA panel for detecting early-stage CRC and advanced adenomas.
Opportunities center on rapid, portable multiplex diagnostics, PCR and ELISA adoption, precision farming and early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results